1166 results about "Ionic compound" patented technology

The present disclosure relates to methods for isolating, amplifying, and/or analyzing nucleic acids in the presence of an anion exchange material by performing the isolation, amplification and/or analysis step in the presence of at least one anionic compound.

The present invention provides a pharmaceutical composition, comprising a non-infectious, non-integrating polynucleotide construct comprising a polynucleotide encoding an interferon ω and one or more cationic compounds. The present invention also provides methods of treating cancer in a mammal, comprising administering into a muscle of the mammal a non-infectious, non-integrating DNA polynucleotide construct comprising a polynucleotide encoding a cytokine. In addition, the present invention also relates to the methodology for selective transfection of malignant cells with polynucleotides expressing therapeutic or prophylactic molecules in intra-cavity tumor bearing mammals. More specifically, the present invention provides a methodology for the suppression of an intra-cavity dissemination of malignant cells, such as intraperitoneal dissemination. Furthermore, the invention relates to compositions and methods to deliver polynucleotides encoding polypeptides to vertebrate cells in vivo, where the composition comprises an aqueous solution of sodium phosphate.

Low melting ionic compounds of the general formula (cation) (R′SO₄) in which R′ is a branched or linear, saturated or unsaturated, aliphatic or alicyclic functionalized or non-functionalized hydrocarbon chain with 3-36 carbon atoms are provided. These compounds can serve as ionic liquids, e.g. as solvents or solvent additives in chemical reactions, as extraction agents or as heat carriers. The compounds comprise a cation and anionic sulfate ester.

The present invention relates to sustained-release pharmaceutical compositions for ionic pharmaceutically active substances (excluding ionic prostanoic acid derivatives) containing ionic compounds having opposite charges to those of the active substances and increasing hydrophobicity of the active substances. More specifically, the invention relates to sustained-release pharmaceutical compositions comprising the ionic pharmaceutically active substances and the ionic compounds having opposite charges to those of the active substances and increasing hydrophobicity of the active substances that contain hydrophobic groups in the molecule thereof. The pharmaceutical composition of the invention can exhibit excellent sustained release effect of the active substance, irrespective of water solubility possessed by the ionic pharmaceutically active substances.

This invention relates to composition containing expandable microspheres and at least one ionic compound and having a zeta potential that is greater than or equal to zero mV at a pH of about 9.0 or less at an ionic strength of from 10⁻⁶ M to 0.1 M., as well as methods of making and using the composition.

The present invention describes methods and processes for the production of proteins, particularly glycoproteins, by animal cell or mammalian cell culture, preferably, but not limited to, fed-batch cell cultures. In one aspect, the methods comprise at least two temperature shifts performed during the culturing period, in which the temperature is lower at the end of the culturing period than at the time of initial cell culture. Throughout their duration, the culturing processes of the invention involving two or more downward shifts in temperature sustain a high viability of the cultured cells, and can yield an increased end titer of protein product, and a high quality of protein product, as determined, e.g., by sialic acid content of the produced protein. In another aspect, the methods comprise the delayed addition of polyanionic compound during the culturing period. The delayed addition of polyanionic compound sustains a high viability of the cultured cells, and can extend the growth phase, delay the onset of the death phase, and arrest the death phase.

A process for the preparation of a catalyst system includes the steps of combining a support material with a first composition which includes at least one aluminoxane in a first solvent to provide an aluminoxane loaded support; and, contacting the aluminoxane loaded support with a second composition which includes at least one metallocene compound, a second solvent, and a cocatalyst, wherein the cocatalyst includes a second portion of the at least one aluminoxane alone or in combination with an ionic compound and/or a Lewis acid.

The present invention provides an ionic compound which: can exert excellent basic performance such as excellent electrochemical stability including an excellent ionic conductivity; is excellent in pH stability; and can suitably find use in a variety of applications, and an electrolyte material, an electrolytic solution, and an electrolytic capacitor each containing the ionic compound. Anionic compound of the present invention has an anion represented by a general formula (1) and a cation represented by a general formula (2):

• where X represents an element selected from B, C, N, O, Al, Si, P, S, As, and Se, M¹ and M² represent linking groups, Q represents a monovalent element or organic group, a represents an integer of 1 or more, and b, c, d, and e each represent an integer of 0 or more;

R_s-LH^⊕  (2)

where L represents an element selected from C, Si, N, P, S, and O, R represents a monovalent element, functional group, or organic group, and s represents an integer of 2, 3, or 4.

The present invention belongs to the field of electrochemical power source material preparing technology, and is especially preparation process of oxygen place doped lithium ferric phosphate powder. The oxygen place doped lithium ferric phosphate as positive pole material in lithium ion cell has the molecular expression LiFeP(MxO4-x), and is prepared through mixing the dopant and the mother body material and sintering the mixture, or through solid phase reaction of the dopant and the mother body material. The preparation process has effective doping in the oxygen place of mother body material and the prepared material can raise the capacity and the circular discharge performance of the cell effectively and thus can find its wide application as positive pole material in secondary lithium ion cell and power cell.

The invention relates to an aqueous dispersion containing a dispersant and a disperse phase containing a hydrophobic material, the dispersant comprising an anionic compound having a molecular weight less than 50,000 and being selected from the group consisting of carbon-containing compounds and silicon-containing compounds, and a cationic organic compound having a molecular weight less than 50,000. The invention further relates to the preparation and use of the dispersion in the production of paper. The invention also relates to a substantially water-free composition containing a hydrophobic material, an anionic compound having a molecular weight less than 50,000 and being selected from carbon-containing compounds and silicon-containing compounds, and a cationic organic compound having a molecular weight less than 50,000, as well as it use in the preparation of an aqueous dispersion.

The invention provides a chemical-mechanical polishing composition containing a ceria abrasive, one or more nonionic polymers, optionally one or more phosphonic acids, optionally one or more nitrogen-containing zwitterionic compounds, optionally one or more sulfonic acid copolymers, optionally one or more anionic copolymers, optionally one or more polymers comprising quaternary amines, optionally one or more compounds that adjust the pH of the polishing compositions, water, and optionally one or more additives. The invention further provides a method of chemically-mechanically polishing a substrate with the inventive chemical-mechanical polishing composition. Typically, the substrate contains silicon oxide, silicon nitride, and/or polysilicon.

The invention discloses a preparation method of chitosan-polyurethane ionic compound elastomeric material, which comprises the following steps: polyisocyanates reacts with polymer polylol and then reacts with diol or diamine, organic solvent and ionization reagent are added in the reactants to react with water for generating anionic waterborne polyurethane and further performs the ionic recombination reaction with cationic chitosan water solution to obtain the microemulsion or latex of chitosan-polyurethane ion composite, and finally the microemulsion or latex of chitosan-polyurethane ion composite is dried and solidified to obtain the chitosan-polyurethane ionic compoundelastomeric material. The chitosan-polyurethane ionic compoundelastomeric material has the advantages of good mechanical property, easy processing, good oil-water resistance property, good cohesive property with parent metal, controllable performance, good biocompatibility, biodegradable property, high biological activity, good blood contact property, good bacteriostatic property, good antibacterial property, and the like, can be applied in fields of mechanical industry, building industry, sport, medical treatment, and the like, and especially has wider purpose in aspects of life science research, medical materials and medical appliances.

The invention concerns novel ionic compounds with low melting point whereof the onium type cation having at least a heteroatom such as N, O, S or P bearing the positive charge and whereof the anion includes, wholly or partially, at least an ion imidide such as (FX¹O)N⁻(OX²F) wherein X¹ and X² are identical or different and comprise SO or PF, and their use as solvent in electrochemical devices. Said composition comprises a salt wherein the anionic charge is delocalised, and can be used, inter alia, as electrolyte.

The present invention is related to hybrid conjugates formed by covalently bonding siRNA (small interfering RNA) molecules to hydrophilic polymers for improving stability of the siRNA molecules effective for delivering the siRNA in vivo, and polyelectrolyte complex micelles formed by ionic interactions between the conjugates and multifunctional cationic compounds. The siRNA-hydrophilic polymer conjugates and polyelectrolyte complex micelles derived therefrom can be used for improving stability of the siRNA molecules in vivo. Consequently, the delivery of siRNA molecules for therapeutic applications into cells can be facilitated, and the siRNA is still active even though a small dose of the siRNA is used.

The present invention relates to a pharmaceutical composition of a biologically active agent and a block copolymer composed of a poly(ethylene oxide) forming hydrophilic segment and a poly(butyl (alkyl)acrylate-co-(alkyl)acrylic acid) that is capable of forming supramolecular assemblies or micelles under favourable conditions. The supramolecular assemblies or micelles formed from said polymers associate or dissociate reversibly upon changes in the environmental pH. The pharmaceutical compositions of the present invention contain hydrophobic drugs, cations or polycationic compounds, which can be delivered to the body by oral route or other routes of administration.

The present application relates to a compound of formula A-X-B, where (i) A-X-B form an ionic compound Ai Xi Bi where Ai and Bi are each individually an organic onium cation; and Xi is anion of the formula Q-R₅₀₀—SO₃⁻ or (ii) A-X-B form a non-ionic compound Ac-Xc-Bc, where Ai, Bi, Q, R₅₀₀, Ac, Bc, and Xc are defined herein. The compounds are useful as photoactive materials.

An object of the present invention is to provide a material for an electrolytic solution having improved ionic conductivity and, showing excellent in low temperature property, being stable with time, and being electrochemically stable at a high potential, and an ionic material-containing composition exhibiting excellent fundamental performance such as electrochemical stability, and preferably used in a variety of utilities. Another object of the present invention is to provide utilities thereof.

The material for an electrolytic solution is the material containing an ionic compound, and the material comprises a cyano group-containing anion represented by the formula (1);

and 1 to 99% by mass of a solvent in 100% by mass of the material for an electrolytic solution.

An ionization method for use with mass spectrometry or ion mobility spectrometry is a small molecule compound(s) as a matrix into which is incorporated analyte. The matrix has attributes of sublimation or evaporation when placed in vacuum at or near room temperature and produces both positive and negative charges. Placing the sample into a region of sub-atmospheric pressure, the region being in fluid communication with the vacuum of the mass spectrometer or ion mobility spectrometer, produces gas-phase ions of the analyte for mass-to-charge or drift-time analysis without use of a laser, high voltage, particle bombardment, or a heated ion transfer region. This matrix and vacuum assisted ionization process can operate from atmosphere or vacuum and produces ions from large (e.g. proteins) and small molecules (e.g. drugs) with charge states similar to those observed in electrospray ionization.

Methods and kits for isolating nucleic acids from a sample, typically a biological sample are disclosed. In certain embodiments, the methods and kits of the invention comprise at least one protease and at least one solid phase. In certain embodiments, the methods and kits of the invention comprise at least one chaotrope and at least one solid phase. In certain embodiments, the inventive methods and kits further comprise at least one chaotrope, at least one zwitterionic compound, at least one cationic detergent, at least one non-ionic detergent, or combinations thereof.

The present invention is directed to a bicomponent strengthening system and the paper webs produced with the bicomponent strengthening system. Through use of the strengthening system, paper webs may be produced in which the strength characteristics of the web may be specifically tailored. The first component of the system comprises a polymer having at least about 1.5 m-eq primary amine functionality per gram of polymer and a molecular weight of at least about 10,000 Daltons. The second component may be either a polymeric anionic compound or a polymeric aldehyde functional compound. For example, the polyamine polymer component may be a polyvinylamine or polysaccharide having primary amine functionality. In one embodiment, the second component may be a cationic polymeric aldehyde functional compound. For example, the second component may be a cationic glyoxylated polyacrylamide. In another embodiment, the second component may be a polymeric anionic compound comprising carboxy functionality.

The invention provides a process for preparation of super-long titanium dioxide nano-tubes arrays, which is provided with catalytic performance. The process for preparation is that titanium or titanium alloys are utilized as anode after surface treatment. Ionic compound with halogen atoms is utilized as solutes, which is dissolved in anhydrous organic solvents to utilize as electrolyte. Platinum electrode is counter electrode. After anodizing and high-temperature annealing, TiO2 nano-tubes arrays of which length is at 30-190 mu m and diameter of tube is at 20-200nm can be achieved on titanium or titanium alloys. The combination of the super-long highly orderly titanium dioxide nano-tubes arrays and matrix, which is prepared by the invention, is more firmly than the combination of traditional titania film and matrix. Film thickness of the super-long highly orderly titanium dioxide nano-tubes arrays is at 30-190 mu m. Thickness which is at the range of the film thickness of the super-long highly orderly titanium dioxide nano-tubes arrays is provided with higher photoelectric conversion efficiencies, which is favorable to application of the super-long titanium dioxide nano-tubes arrays in the field of photocatalysis, solar cell, sensor and the like.

The invention discloses a novel rare earth-containing composite antibacterial agent and application thereof. The rare-earth composite antibacterial agent comprises more than one lanthanoid inorganic compound and more than one antibacterial ionic compound and also comprises a carrier further, wherein the carrier comprises more than one inorganic lamellar material and/or more than one porous material; and the lanthanoid inorganic compounds and the antibacterial ionic compounds are loaded on the inorganic lamellar materials and/or the porous materials. The prepared rare-earth composite antibacterial agent has the characteristics of high color change resistance, heat resistance and antibacterial property and lasting antibiosis, and does not influence the mechanical property and heat resistance of materials when applied to the high polymer materials such as plastics and the like.